600 patients66,869 observations120 daysLIVE

Patient P-01751

Synthetic patientNBL-101 · Day 110 · 45–54 · M · baseline S14Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Stable
GI state
Unstable
Inflammatory state
Unstable
Nutritional resilience
Unstable
Discontinuation risk
95%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S14
  2. Day 45 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 67 ME-01 recommendedMonitoring Escalation ME-01
  4. Day 68 Patient acceptedStarted ME-01 in the companion
  5. Day 71 Deterioration detected before clinical escalationMonitoring Escalation ME-01

What changed?

Trajectory began diverging from predicted response on Day 45.

Primary contributors, last 14 days
  • GI instability-7
  • Inflammatory activity-5
  • Nutritional resilience+3
  • Toxicity+3
  • Treatment adherence+2

What helped?

  • Monitoring Escalation ME-01Day 67
    Result: deterioration detected before clinical escalation
LIFE OS recommendation
GI Support Protocol GI-04
89%
probability of meaningful tolerance improvement
  • 284 similar trajectories
  • 84% showed improvement
  • median effect visible after 8 days

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden
Companion
62.2/100
stable · -1.1 vs previous 14 d
Toxicity
Blood
55.4/100
stable · +0.1 vs previous 14 d
Sleep quality
Wearable
33.9/100
stable · +0.5 vs previous 14 d
Energy level
Daily log
1.7/10
improving · +0.2 vs previous 14 d
Stress level
Daily log
7.8/10
stable · -0.2 vs previous 14 d
Steps
Wearable
4,107
stable · -177 vs previous 14 d
Adherence
Companion
44.9 %
improving · +1.8 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards restoration · 26 from the failing basin, 67 from restoration.

Would help
  • GI-04 GI Support Protocol
    73% improved among 123 similar · onset 8 d · confidence 91%
  • NP-02 Dietary Support Protocol
    63% improved among 64 similar · onset 10 d · confidence 69%
  • SC-12 Supportive Compound
    76% improved among 51 similar · onset 6 d · confidence 69%
Would not help
  • Keep fat low
    GI +3.8 next day on high-intake days · n 23
  • Keep alcohol low
    GI +3.2 next day on high-intake days · n 17
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Dietary fat load
    +3.8detractor · 95%
  • Alcohol
    +3.2detractor · 95%
  • Simple carbohydrates
    +1.9no signal · 54%
  • Spicy / capsaicin
    +1no signal · 28%
  • Insoluble fibre
    +0.5no signal · 15%
  • Histamine load
    -0.3no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Inflammatory signalling 70
    • DNAIL6 -174 variant raises baseline inflammatory tone
    • MicrobiomeBacteroides fragilis expansion
    • BloodInflammatory load index 62
  • Drug metabolism and exposure 60
    • DNACYP2D6 poor metabolizer → higher exposure
    • BloodToxicity index 55
  • Butyrate / short-chain fatty acid production 55
    • MicrobiomeButyrate capacity 33/100
    • Daily logFibre intake low in recent food logs
  • Autonomic recovery 45
    • WearableResting HR 87 bpm
    • WearableShort sleep window
  • Mucosal barrier integrity 20
    • Daily logGI symptom score 62 and rising
DNA
Fictional pharmacogenomic panel
  • IL6 -174 G/C
    Higher inflammatory tone
  • CYP2D6 Poor metabolizer
    Higher exposure at standard dose
  • MTHFR C677T
    Reduced folate turnover
Microbiome
Shannon diversity 2 · butyrate capacity 33/100
  • Akkermansia muciniphilaNormal
  • Faecalibacterium prausnitziiNormal
  • Bacteroides fragilisHigh
  • Bifidobacterium longumLow
  • EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
HRV
39 ms
Sleep
6.2 h
Steps
4,348
Resting HR
87 bpm
Daily log: GI score 62, nutritional resilience 37, adherence 45.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
  • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Track each bowel movement today: time, stool form, urgency, overnight waking
  • A 15-minute walk after lunch
  • Protect a 7.5-hour sleep window; screens off 30 minutes before
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • Electrolyte solution, one sachet after any loose stool
  • Fictional demo item: oral nutrition supplement with lunch

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0131169%S14ME-01improved49
P-0173260%S14ME-01improved45
P-0160559%S14ME-01improved41
P-0183057%S1444
P-0146355%S14NP-02no change41
P-0158255%S14GI-04no change45
P-0159555%S14GI-04no change51
P-0139654%S14GI-04worsened51
P-0132853%S14SC-12no change49
P-0176053%S1442
P-0145452%S14GI-04no change49
P-0156452%S14ME-01improved39